Skip to main content
. 2022 Feb 17;28(3):408–424. doi: 10.3350/cmh.2022.0012

Table 1.

Differences between small-interfering RNA and antisense oligonucleotides

siRNA ASO
Structure Double-stranded RNA + two 3’ end overhanging nucleotides Single-stranded DNA + flanking by modified RNA-like segments (gapmer)
Ideal length 21 nucleotides 15–25 nucleotides
Cellular entry Requires conjugation to carrier for hepatocyte uptake Can be taken into hepatocytes in unconjugated form
Accumulation In endosomes In cytoplasm
Dosing frequency Less frequent (monthly) More frequent (weekly or biweekly)
Target mRNA binding Requires RISC formation Can bind to target alone
Primary gene silencing mechanism Target RNA cleavage by Argonaute Target RNA cleavage by RNAse-H

siRNA, small-interfering RNA; ASO, antisense oligonucleotide; mRNA, messenger RNA; RISC, RNA-induced silencing complex.